UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 97

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History

Viruses, 2022-07, Vol.14 (8), p.1691

2022

Volltextzugriff (PDF)

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

PloS one, 2015-06, Vol.10 (6), p.e0130209-e0130209

2015

Volltextzugriff (PDF)

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine

Viruses, 2022-03, Vol.14 (4), p.701

2022

Volltextzugriff (PDF)

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection

Viruses, 2023-11, Vol.15 (11), p.2257

2023

Volltextzugriff (PDF)

A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection

PloS one, 2014-10, Vol.9 (10), p.e110782-e110782

2014

Volltextzugriff (PDF)

Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume

Surgery, 2017-09, Vol.162 (3), p.483-499

2017

Volltextzugriff (PDF)

Primary sclerosing cholangitis: Is qualitative and quantitative 3 T MR imaging useful for the evaluation of disease severity?

European journal of radiology Open, 2024-12, Vol.13, p.100595, Article 100595

2024

Volltextzugriff (PDF)

Stauffer syndrome in a tumor of the pancreatic tail: A paracrine pathogenesis, rather than an inflammatory disimmune phenomenon – a case report

Current problems in cancer. Case reports, 2024-09, Vol.15, p.100320, Article 100320

2024

Volltextzugriff (PDF)

Liver stiffness in the hepatitis B virus carrier： A non-invasive marker of liver disease influenced by the pattern of transaminases

World journal of gastroenterology : WJG, 2008-10, Vol.14 (40), p.6154-6162

2008

Volltextzugriff (PDF)

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

Journal of hepatology, 2002-02, Vol.36 (2), p.263-270

2002

Volltextzugriff (PDF)

Hepatic adrenal rest tumor in a patient with multifactorial liver cirrhosis: a case report with CT and MRI findings and pathologic correlation

Egyptian Journal of Radiology and Nuclear Medicine, 2021-11, Vol.52 (1), p.280, Article 280

2021

Volltextzugriff (PDF)

Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent - A Critical Reasoning

Frontiers in pediatrics, 2022-05, Vol.10, p.896903

2022

Volltextzugriff (PDF)

Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis

World journal of gastroenterology : WJG, 2009-02, Vol.15 (5), p.531-537

2009

Volltextzugriff (PDF)

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

Journal of hepatology, 2005, Vol.42 (1), p.61-67

2005

Volltextzugriff (PDF)

Why and when could nucleos(t)ide analogues treatment be withdrawn?

Digestive and liver disease, 2024-10

2024

Volltextzugriff (PDF)

SAT-245 Semaglutide for type 2 diabetes control in metabolic dysfunction-associated steatotic liver disease (MASLD): a two-way effect?

Journal of hepatology, 2024-06, Vol.80, p.S619-S619

2024

Volltextzugriff (PDF)

Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

Gastroenterology (New York, N.Y. 1943), 2010-08, Vol.139 (2), p.483-490

2010

Volltextzugriff (PDF)

HDV RNA levels <1000 IU/ml and total anti-HDV titers <1:1000 identify chronic hepatitis D subjects without active liver disease

Journal of hepatology, 2023-06, Vol.78, p.S1091

2023

Volltextzugriff (PDF)

WED-157 - HDV RNA levels <1000 IU/ml and total anti-HDV titers <1:1000 identify chronic hepatitis D subjects without active liver disease

Journal of hepatology, 2023-06, Vol.78, p.S1091-S1091

2023

Volltextzugriff (PDF)

WED-314-YI Head-to-head comparison of two different ultrasound systems to measure the liver attenuation parameter

Journal of hepatology, 2024-06, Vol.80, p.S549-S549

2024

Volltextzugriff (PDF)

FRI-014 Comparison of two ultrasound diagnostic systems for measuring liver stiffness in clinical practice

Journal of hepatology, 2024-06, Vol.80, p.S622-S622

2024

Volltextzugriff (PDF)

Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease

Diabetes/metabolism research and reviews, 2024-02, Vol.40 (2), p.e3736-n/a

2024

Volltextzugriff (PDF)

MR imaging features of multiple biliary hamartomas (Von Meyenburg Complex): A pictorial review and differential diagnosis

Journal of medical imaging and radiation oncology, 2021-06, Vol.65 (3), p.323-330

2021

Volltextzugriff (PDF)

SAT-456 - Shortcomings of “FIB-4 First” strategy in screening for non-alcoholic fatty liver disease (NAFLD) patients at risk for disease progression in a real life setting: will we be detracting therapeutic opportunities from patients?

Journal of hepatology, 2023-06, Vol.78, p.S691-S691

2023

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection

A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection

Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume

Primary sclerosing cholangitis: Is qualitative and quantitative 3 T MR imaging useful for the evaluation of disease severity?

Stauffer syndrome in a tumor of the pancreatic tail: A paracrine pathogenesis, rather than an inflammatory disimmune phenomenon – a case report

Liver stiffness in the hepatitis B virus carrier： A non-invasive marker of liver disease influenced by the pattern of transaminases

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

Hepatic adrenal rest tumor in a patient with multifactorial liver cirrhosis: a case report with CT and MRI findings and pathologic correlation

Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent - A Critical Reasoning

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study

Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

Why and when could nucleos(t)ide analogues treatment be withdrawn?

SAT-245 Semaglutide for type 2 diabetes control in metabolic dysfunction-associated steatotic liver disease (MASLD): a two-way effect?

Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

HDV RNA levels <1000 IU/ml and total anti-HDV titers <1:1000 identify chronic hepatitis D subjects without active liver disease

WED-157 - HDV RNA levels <1000 IU/ml and total anti-HDV titers <1:1000 identify chronic hepatitis D subjects without active liver disease

WED-314-YI Head-to-head comparison of two different ultrasound systems to measure the liver attenuation parameter

FRI-014 Comparison of two ultrasound diagnostic systems for measuring liver stiffness in clinical practice

Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease

MR imaging features of multiple biliary hamartomas (Von Meyenburg Complex): A pictorial review and differential diagnosis

SAT-456 - Shortcomings of “FIB-4 First” strategy in screening for non-alcoholic fatty liver disease (NAFLD) patients at risk for disease progression in a real life setting: will we be detracting therapeutic opportunities from patients?

Suchergebnisse filtern